---
document_datetime: 2025-09-19 16:30:44
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/jubbonti-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: jubbonti-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 1.8513407
conversion_datetime: 2025-12-27 19:29:51.351745
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Jubbonti

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                      | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                               |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/954/2 02409    | Periodic Safety Update EU Single assessment - denosumab (indicated for osteoporosis and for bone loss associated with hormone ablation in prostate cancer) | 22/05/2025                          | 17/07/2025                                  | SmPC                             | Please refer to PSUSA/00000954/202409 EPAR: Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation |
| N/0006               | Minor change in labelling or package leaflet not                                                                                                           | 09/01/2025                          | 17/07/2025                                  | Labelling and                    |                                                                                                                                                       |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                            |            |            | PL                               |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0005   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                               | 20/11/2024 | 17/07/2025 | SmPC, Annex II, Labelling and PL | To update sections 4.4 and 4.8 of the SmPC in order to update a warning regarding hypocalcaemia and to include reports of life-threatening events and fatal cases occurred in the post marketing setting based on the cumulative review of the MAH of the reference products safety database and literature. The Package Leaflet is updated accordingly. In addition the MAH has taken this opportunity to update the details for the local representatives in CZ, LU, DK, NO, SV and UK (NI). |
| WS/2772   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.z - Change in control of the AS - Other variation                                                                                                                                      | 07/11/2024 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| II/0002/G | This was an application for a group of variations. B.I.a.3.c - Change in batch size (including batch size ranges) of AS or intermediate - The change requires assessment of the comparability of a biological/immunological AS B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation | 31/10/2024 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| IB/0003/G | This was an application for a group of variations. B.II.e.3.z - Change in test procedure for the                                                                                                                                                                                                                                           | 08/10/2024 | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

<div style=\"page-break-after: always\"></div>

|         | immediate packaging of the finished product - Other variation B.II.e.3.z - Change in test procedure for the immediate packaging of the finished product - Other variation   |            |     |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IA/0001 | B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits                                  | 01/08/2024 | n/a |